Table 3. Median laboratory values over time, compared by treatment group.
Median Value (range) | Baseline | Day 3 | Day 7 | Day 10 | p value* |
WBC in TH/CUMM | 0.017 | ||||
TM | 7.2 (4.0,12.5) | 6.8 (3.6, 11.2) | 7.0 (3.8, 12.2) | 6.4 (3.9, 10.3) | |
SSG | 7.9 (3.5, 12.4) | 5.9 (3.0, 9.0) | 5.5 (2.9, 12.0) | 4.9 (3.1, 10.6) | |
Hematocrit % | <0.001 | ||||
TM | 44.6 (36.8, 56.6) | 45.4 (36.9, 53.5) | 44.8 (38.3, 52.6) | 45.9 (40.9, 50.9) | |
SSG | 44.3 (35.4, 55.3) | 44.1 (37.7, 51.5) | 44.0 (38.1, 51.0) | 43.1 (37.6, 47.7) | |
Platelets TH/CUMM | <0.0005 | ||||
TM | 250 (171, 353) | 233 (170, 323) | 237 (167, 302) | 236 (181, 291) | |
SSG | 250 (179, 333) | 229 (180, 310) | 206 (134, 289) | 196 (133, 294) | |
Amylase U/L | <0.0005 | ||||
TM | 51 (<30, 101) | 48 (30, 104) | 52 (30, 93) | 52 (33, 88) | |
SSG | 50 (<30, 107) | 127 (34, 420) | 152 (<30, 511) | 143 (<30, 348) | |
Lipase U/L | <0.0005 | ||||
TM | 72 (29, 254) | 61 (29, 224) | 75 (28, 212) | 70 (19, 253) | |
SSG | 76 (26, 204) | 512 (95, 2479) | 587 (103, 6009) | 515 (97, 2385) | |
Creatinine mg/dL | 0.92 | ||||
TM | 1.0 (0.8, 1.2) | 1.0 (0.9, 1.2) | 1.0 (0.8, 1.2) | 1.0 (0.8, 1.2) | |
SSG | 1.0 (0.7, 1.3) | 1.0 (0.8, 1.3) | 0.9 (0.7, 1.4) | 0.9 (0.7, 1.3) | |
CK U/L | 0.91 | ||||
TM | 103 (60, 17763) | 102 (57,1475) | 117 (54, 522) | 110 (57, 572) | |
SSG | 78 (52, 220) | 97 (39, 453) | 90 (34, 206) | 78 (34, 404) | |
ALT U/L | <0.0005 | ||||
TM | 30 (22, 86) | 29 (19, 86) | 32 (17, 73) | 30 (21, 77) | |
SSG | 27 (16, 61) | 27 (14, 67) | 46 (22, 400) | 71 (28, 305) | |
AST U/L | <0.0005 | ||||
TM | 22 (18, 187) | 25 (17, 70) | 25 (17, 35) | 27 (16, 55) | |
SSG | 23 (13, 42) | 23 (14, 52) | 37 (18, 285) | 52 (26, 135) | |
QTc ms | 0.24 | ||||
TM | 403 (369, 437) | 403 (319, 440) | 401 (378, 457) | 402 (372, 457) | |
SSG | 399 (377,450) | 402 (377, 438) | 403 (368, 447) | 403 (376, 438) |
*p Values represent interaction of treatment and time (e.g. a significant p value indicates that the effect of the treatment over time was significantly different).